Free Trial
OTCMKTS:GRRMF

Gerresheimer (GRRMF) Stock Price, News & Analysis

Gerresheimer logo
$70.55 -3.40 (-4.60%)
As of 04/3/2025 03:18 PM Eastern

About Gerresheimer Stock (OTCMKTS:GRRMF)

Key Stats

Today's Range
$69.75
$72.66
50-Day Range
$69.08
$91.72
52-Week Range
$66.93
$114.50
Volume
972 shs
Average Volume
950 shs
Market Capitalization
N/A
P/E Ratio
31.08
Dividend Yield
0.73%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Remove Ads

Gerresheimer Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

GRRMF MarketRank™: 

Gerresheimer scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Gerresheimer.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Gerresheimer is 31.08, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.24.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Gerresheimer is 31.08, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.88.

  • Read more about Gerresheimer's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Gerresheimer has a short interest ratio ("days to cover") of 984, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Gerresheimer has recently increased by 44.49%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Gerresheimer pays a meaningful dividend of 1.30%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Gerresheimer does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Gerresheimer is 22.82%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Gerresheimer's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Gerresheimer has a short interest ratio ("days to cover") of 984, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Gerresheimer has recently increased by 44.49%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Gerresheimer has a news sentiment score of -0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Gerresheimer this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Gerresheimer insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    53.23% of the stock of Gerresheimer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Gerresheimer's insider trading history.
Receive GRRMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

GRRMF Stock News Headlines

Gerresheimer (0NTI) Gets a Buy from Bernstein
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
Gerresheimer downgraded to Sector Weight from Overweight at KeyBanc
See More Headlines

GRRMF Stock Analysis - Frequently Asked Questions

Gerresheimer's stock was trading at $69.75 on January 1st, 2025. Since then, GRRMF shares have increased by 1.1% and is now trading at $70.55.
View the best growth stocks for 2025 here
.

Shares of GRRMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/04/2025
Next Earnings (Estimated)
4/08/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:GRRMF
CIK
N/A
Fax
N/A
Employees
11,947
Year Founded
N/A

Profitability

Trailing P/E Ratio
31.08
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Spring 2025 Cover

Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.

Get This Free Report

This page (OTCMKTS:GRRMF) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners